Intuitive Surgical price target raised to $315 from $285 at Stifel

Stifel raised the firm’s price target on Intuitive Surgical to $315 from $285 and keeps a Buy rating on the shares. Intuitive Surgical reported its strongest procedural growth quarter, excluding Q2 of 2021, since Q1 of 2012, the analyst tells investors. As the firm previously indicated in its early Q1 2023 MedTech earnings bottom line, Intuitive Surgical’s earnings calls "seem to indicate" the macro-operating environment is considerably improving and the companies most leveraged for recovery, such as Intuitive, are likely to see the most upside, Stifel says.